Poland
# |
Name |
EBIT |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 2.09 M
|
Dec. 31, 2023 | USD 1.13 | -2.47% |
|
Poland |
|
2 |
USD -3.22 M
|
Dec. 31, 2023 | USD 9.53 | 2.20% |
|
Poland |
|
3 |
USD -4.63 M
|
Dec. 31, 2023 | USD 2.23 | -2.90% |
|
Poland |
|
4 |
USD -8.08 M
|
Dec. 31, 2023 | USD 3.74 | -3.55% |
|
Poland |
|
5 |
USD -17.80 M
|
Dec. 31, 2023 | USD 12.20 | -4.46% |
|
Poland |
The Vaccines company in Poland with the highest EBIT is Synthaverse S.A. (Warsaw Stock Exchange: SVE.WA) at USD 2.09 M.
The Vaccines company in Poland with the lowest EBIT is Captor Therapeutics Spolka Akcyjna (Warsaw Stock Exchange: CTX.WA) at USD -17.80 M.
The top 10 Vaccines companies in Poland by EBIT are Synthaverse S.A., Poltreg S.A., Molecure S.A., Pure Biologics Spólka Akcyjna and Captor Therapeutics Spolka Akcyjna.
The bottom 10 Vaccines companies in Poland by EBIT are Captor Therapeutics Spolka Akcyjna, Pure Biologics Spólka Akcyjna, Molecure S.A., Poltreg S.A. and Synthaverse S.A..